Part 2: IDH1 & IDH2 Inhibitors In Newly Diagnosed AML


Expert continues discussion of IDH1 and IDH2 inhibitors in AML and examines prioritization of IDH1 and IDH2 inhibitors versus venetoclax in newly diagnosed AML.

Related Videos
MP Studio -
Image credit: David A Litman |
Credit: AkuAku -
Image credit: Halfpoint |
Credit: AkuAku -
Image Credit: © Mongta Studio -
Image credit: Halfpoint |
luchschenF -
© 2024 MJH Life Sciences

All rights reserved.